Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Monday, November 10, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
City Therapeutics Announces Submission of Application for Clinical Trial of CITY-FXI, an Investigational RNAi Anticoagulant
Life Sciences Times
-
November 10, 2025
Pharma
AstraZeneca Reports Positive Phase III NATRON Results Showing FASENRA Delayed Disease Worsening in Hypereosinophilic Syndrome
Life Sciences Times
-
November 7, 2025
Pharma
Astria Therapeutics Reports Final Positive Results from All Enrolled HAE Patients in ALPHA-STAR Phase 1b/2 Trial of Navenibart
Life Sciences Times
-
November 6, 2025
Pharma
Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis
Life Sciences Times
-
October 31, 2025
Pharma
Delix Therapeutics Reports Positive Phase Ib Results for Zalsupindole and FDA Clearance for Phase II Trial with At-Home Administration
Life Sciences Times
-
October 28, 2025
Pharma
Allecra Therapeutics Announces U.S. FDA Approval for EXBLIFEP® for the Treatment of Complicated Urinary Tract Infections
Life Sciences Times
-
February 27, 2024
0
People on the Move
Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Appoints Ophthalmology Innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair
Life Sciences Times
-
February 26, 2024
0
Pharma
New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster
Life Sciences Times
-
February 5, 2024
0
Pharma
AustinPx Partners with Microsize on KinetiSol® Technology
Life Sciences Times
-
January 31, 2024
0
Pharma
Takeda’s GAMMAGARD LIQUID® Approved by U.S. FDA for Adults with Chronic Inflammatory Demyelinating Polyneuropathy
Life Sciences Times
-
January 29, 2024
0
Pharma
Integrated Biosciences Announces Nature Publication Identifying New Class of Antibiotics Discovered Via Company’s AI-Powered Platform
Life Sciences Times
-
December 20, 2023
0
Pharma
US WorldMeds Announces FDA Approval of IWILFIN™ (eflornithine) to Strengthen Fight Against Aggressive Childhood Cancer
Life Sciences Times
-
December 14, 2023
0
Pharma
QPS Continues UPLC-HRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development
Life Sciences Times
-
December 14, 2023
0
Pharma
AscellaHealth and Tilde Sciences Team Up to Launch Best-in-Class Patient-Centric Program for Increased Access to Daraprim® and Enhanced Patient Outcomes
Life Sciences Times
-
December 12, 2023
0
Pharma
Alzamend Neuro Receives FDA “Study May Proceed” Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic...
Life Sciences Times
-
December 11, 2023
0
Pharma
Amylyx Pharmaceuticals Announces Publication of Data Showing the Effect of AMX0035 on Plasma Neuroinflammatory Biomarkers in ALS
Life Sciences Times
-
December 4, 2023
0
Pharma
Aptar Awarded US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers
Life Sciences Times
-
December 4, 2023
0
1
...
27
28
29
...
83
Page 28 of 83
Most Read
Tandem Mobi Receives FDA Clearance for Use with Android Smartphones
November 10, 2025
Earned Expands Services with Addition of Dental & Medical Counsel, Bringing Specialized Legal Support for Healthcare Professionals
November 10, 2025
Dr. Nina Kottler Named Chief Medical AI Officer of Mosaic Clinical Technologies
November 10, 2025
Kaneka Expands Global Availability of i-ED Coil with European Launch
November 10, 2025